Raricap-S 200Mg/10Ml Inj Substitute

Substitutes of Raricap-S 200Mg/10Ml Inj meet the same safety and efficacy standards as Raricap-S 200Mg/10Ml Inj, but small differences in absorption or formulation can exist. A doctor can help you choose the right one for your needs.

Yes. Substitutes of Raricap-S 200Mg/10Ml Inj may vary in color, size, or shape due to differences in manufacturing and branding, but this does not affect how they work.

Yes, it’s generally safe to switch between multiple substitutes of Raricap-S 200Mg/10Ml Inj if they have the same salt and strength. However, always inform your doctor so they can monitor how your body responds.

Yes, many people safely use substitutes of Raricap-S 200Mg/10Ml Inj for long-term treatment. Just ensure it’s done under medical supervision.

If your symptoms stay under control or lab results remain stable, the substitute for Raricap-S 200Mg/10Ml Inj is likely working well. Regular follow-ups with your doctor are important.

Absolutely. Even with the same salt, small differences can affect how your body responds when switching from Raricap-S 200Mg/10Ml Inj to its substitute. Always consult your doctor before switching.

Raricap-S 200Mg/10Ml Inj is used to treat iron deficiency and anaemia (deficiency of iron and haemoglobin).

Raricap-S 200Mg/10Ml Inj contains Elemental Iron. It works by boosting the production of red blood cells (RBC) in the body, thus treating iron deficiency and its associated anaemia.

Raricap-S 200Mg/10Ml Inj should be used with caution and only under doctor's supervision if you have heart, liver or kidney diseases, low blood pressure, iron overload disorders like hemochromatosis, lupus (immune disorder), rheumatoid arthritis, asthma, and eczema.

Raricap-S 200Mg/10Ml Inj can be given to patients above 65 years of age under the supervision of a doctor. However, due to the reduced liver, kidney and heart function in older people who also use other medicines, Raricap-S 200Mg/10Ml Inj should be cautiously administered.

Raricap-S 200Mg/10Ml Inj may cause constipation as one of its side effects. Eating fibre-rich foods like vegetables, fresh fruits, and cereals and drinking plenty of water can help relieve symptoms.

Antacids may interfere with the absorption of iron. Hence it is advised to take Raricap-S 200Mg/10Ml Inj two hours before or four hours after taking antacids.

Raricap-S 200Mg/10Ml Inj may cause side effects such as nausea, vomiting, taste changes, constipation, headache, back pain or cough. If these side effects persist or worsen, please consult your doctor.

Iron-deficiency or anemia can be defined as a lack of adequate amounts of healthy red blood cells, which carry oxygen to the body's tissues. Lack of red blood cells may cause pale skin, weakness, fatigue (overtiredness), brittle nails, etc.

The food sources of iron include white beans, spinach, lentils, peas and kidney beans, lean meat, chicken, seafood, nuts and some dried fruits, such as raisins. Also, iron-protected breakfast cereals and bread.

There is limited information on the safety of Raricap-S 200Mg/10Ml Inj in pregnancy. Therefore, please let your doctor know if you are pregnant or planning to conceive before starting Raricap-S 200Mg/10Ml Inj.

Anemia is a blood disorder which occurs when the number of red blood cells (RBCs) that carry oxygen is lower than usual. As a result, your tissues and organs don’t get adequate oxygen. Megaloblastic anemia is a form of anemia characterized by very large red blood cells and a decrease in their number. Generally, megaloblastic anemia is due to vitamin B12 or folic acid deficiency.

Raricap-S 200Mg/10Ml Inj starts working within 5 minutes of giving it. However, the duration may vary depending on the severity, dose, type of cancer and other cancer medications used along with Raricap-S 200Mg/10Ml Inj.

Your doctor will advise blood tests to check your levels of serum methotrexate concentration (in case of methotrexate chemotherapy or overdose) to determine the best dose and duration of treatment with Raricap-S 200Mg/10Ml Inj. A complete blood count may also be recommended to monitor the number of red blood cells (in case of megaloblastic anemia). In order to prevent hypercalcemia (excess calcium), your calcium levels will also be monitored since Raricap-S 200Mg/10Ml Inj contains calcium.

Adult’s urine output should be maintained above 2,500 mL/24hr by increasing oral or intravenous fluids 12 hours before and for 36 hours after the end of methotrexate infusion. Monitor alkalinization of urine (this enhances drug excretion) so that the urinary pH is greater than 7.0 before methotrexate infusion. Drinks, foods and drugs that may increase urinary acidity should be avoided during the therapy. Finally, blood methotrexate concentration should be measured at least 24, 48, and 72 hours after starting the methotrexate infusion.